These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6995308)

  • 81. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.
    Møller AK; Leatham MP; Conway T; Nuijten PJ; de Haan LA; Krogfelt KA; Cohen PS
    Infect Immun; 2003 Apr; 71(4):2142-52. PubMed ID: 12654836
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Proteolytic digestion and labelling studies of the organization of the proteins in the outer membrane of Escherichia coli.
    Reithmeier RA; Bragg PD
    Can J Biochem; 1977 Oct; 55(10):1082-90. PubMed ID: 334351
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.
    Ogata RT; Levine RP
    J Immunol; 1980 Oct; 125(4):1494-8. PubMed ID: 6997381
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Septicemia-inducing Escherichia coli O115:K"V165"F165(1) resists killing by porcine polymorphonuclear leukocytes in vitro: role of F165(1) fimbriae and K"V165" O-antigen capsule.
    Ngeleka M; Martineau-Doizé B; Fairbrother JM
    Infect Immun; 1994 Feb; 62(2):398-404. PubMed ID: 7507891
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Architecture of the outer membrane of Escherichia coli K12. I. Action of phospholipases A2 and C on wild type strains and outer membrane mutants.
    van Alphen L; Lugtenberg B; van Boxtel R; Verhoef K
    Biochim Biophys Acta; 1977 Apr; 466(2):257-68. PubMed ID: 322715
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing.
    McCallum KL; Laakso DH; Whitfield C
    Can J Microbiol; 1989 Nov; 35(11):994-9. PubMed ID: 2482125
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mode of insertion of lipopolysaccharide into the outer membrane of escherichia coli.
    Kulpa CF; Leive L
    J Bacteriol; 1976 Apr; 126(1):467-77. PubMed ID: 770432
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.
    Ngeleka M; Harel J; Jacques M; Fairbrother JM
    Infect Immun; 1992 Dec; 60(12):5048-56. PubMed ID: 1452337
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Escherichia coli K-12 tolF mutants: alterations in protein composition of the outer membrane.
    Chai TJ; Foulds J
    J Bacteriol; 1977 May; 130(2):781-6. PubMed ID: 400794
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of antibodies and complement on the interaction between Escherichia coli 0111:B4 and polymorphonuclear leukocytes.
    Rottini GD; Cian F; Tedesco F; de Nicola G; Patriarca P
    Infection; 1979; 7(4):160-5. PubMed ID: 389802
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Quantitative measurement of the outer membrane permeability in Escherichia coli lpp and tol-pal mutants defines the significance of Tol-Pal function for maintaining drug resistance.
    Kowata H; Tochigi S; Kusano T; Kojima S
    J Antibiot (Tokyo); 2016 Dec; 69(12):863-870. PubMed ID: 27168313
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.
    Putrinš M; Kogermann K; Lukk E; Lippus M; Varik V; Tenson T
    Infect Immun; 2015 Mar; 83(3):1056-67. PubMed ID: 25561706
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.
    Binns MM; Mayden J; Levine RP
    Infect Immun; 1982 Feb; 35(2):654-9. PubMed ID: 7035371
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of the effects of different lipopolysaccharides on the serum bactericidal reactions of two strains of Escherichia coli.
    Allen RJ; Scott GK
    Infect Immun; 1981 Feb; 31(2):831-2. PubMed ID: 7012024
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Vwa+ phenotype of Yersinia enterocolitica.
    Perry RD; Brubaker RR
    Infect Immun; 1983 Apr; 40(1):166-71. PubMed ID: 6832830
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
    Zollinger WD; Mandrell RE
    Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
    Goldman RC; Joiner K; Leive L
    J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhibition of serum bactericidal reaction by lipopolysaccharide.
    Sansano M; Reynard AM; Cunningham RK
    Infect Immun; 1985 Jun; 48(3):759-62. PubMed ID: 4039705
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.
    Vandenbosch JL; Rabert DK; Jones GW
    Infect Immun; 1987 Nov; 55(11):2645-52. PubMed ID: 3312005
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.